annual operating expenses:
$671.77M+$291.28M(+76.55%)Summary
- As of today (September 17, 2025), MDGL annual total operating expenses is $671.77 million, with the most recent change of +$291.28 million (+76.55%) on December 31, 2024.
- During the last 3 years, MDGL annual operating expenses has risen by +$429.29 million (+177.04%).
- MDGL annual operating expenses is now at all-time high.
Performance
MDGL Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$250.56M+$38.89M(+18.37%)Summary
- As of today (September 17, 2025), MDGL quarterly total operating expenses is $250.56 million, with the most recent change of +$38.89 million (+18.37%) on June 30, 2025.
- Over the past year, MDGL quarterly operating expenses has increased by +$74.29 million (+42.15%).
- MDGL quarterly operating expenses is now at all-time high.
Performance
MDGL quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MDGL Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +76.5% | +42.1% |
| 3 y3 years | +177.0% | +257.1% |
| 5 y5 years | +607.3% | +399.0% |
MDGL Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +177.0% | at high | +257.1% |
| 5 y | 5-year | at high | +607.3% | at high | +399.0% |
| alltime | all time | at high | >+9999.0% | at high | +312.0% |
MDGL Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $250.56M(+18.4%) |
| Mar 2025 | - | $211.67M(+27.1%) |
| Dec 2024 | $671.77M(+76.6%) | $166.51M(-5.4%) |
| Sep 2024 | - | $176.03M(-0.1%) |
| Jun 2024 | - | $176.27M(+16.1%) |
| Mar 2024 | - | $151.87M(+29.8%) |
| Dec 2023 | $380.50M(+29.6%) | $117.03M(+18.9%) |
| Sep 2023 | - | $98.40M(+14.0%) |
| Jun 2023 | - | $86.32M(+10.4%) |
| Mar 2023 | - | $78.21M(-8.2%) |
| Dec 2022 | $293.57M(+21.1%) | $85.17M(+6.1%) |
| Sep 2022 | - | $80.29M(+14.4%) |
| Jun 2022 | - | $70.16M(+22.1%) |
| Mar 2022 | - | $57.48M(-10.9%) |
| Dec 2021 | $242.48M(+17.3%) | $64.50M(+2.3%) |
| Sep 2021 | - | $63.06M(+2.3%) |
| Jun 2021 | - | $61.65M(+16.6%) |
| Mar 2021 | - | $52.87M(-11.1%) |
| Dec 2020 | $206.67M(+117.6%) | $59.44M(+1.3%) |
| Sep 2020 | - | $58.67M(+16.8%) |
| Jun 2020 | - | $50.21M(+32.6%) |
| Mar 2020 | - | $37.88M(+26.6%) |
| Dec 2019 | $94.97M(+133.4%) | $29.93M(+23.8%) |
| Sep 2019 | - | $24.17M(+6.6%) |
| Jun 2019 | - | $22.68M(+25.3%) |
| Mar 2019 | - | $18.09M(+25.4%) |
| Dec 2018 | $40.68M(+26.9%) | $14.43M(+27.6%) |
| Sep 2018 | - | $11.31M(+45.0%) |
| Jun 2018 | - | $7.80M(+10.7%) |
| Mar 2018 | - | $7.05M(-20.4%) |
| Dec 2017 | $32.06M(+27.1%) | $8.85M(+2.6%) |
| Sep 2017 | - | $8.63M(+2.3%) |
| Jun 2017 | - | $8.43M(+38.8%) |
| Mar 2017 | - | $6.08M(-20.9%) |
| Dec 2016 | $25.22M(+680.2%) | $7.68M(-45.0%) |
| Sep 2016 | - | $13.96M(+429.0%) |
| Jun 2016 | - | $2.64M(+257.6%) |
| Mar 2016 | - | $738.00K(-27.4%) |
| Dec 2015 | $3.23M(-96.1%) | $1.02M(+18.2%) |
| Sep 2015 | - | $860.00K(-95.6%) |
| Jun 2015 | - | $19.34M(-4.1%) |
| Mar 2015 | - | $20.16M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $83.95M(-4.1%) | $19.73M(+2.3%) |
| Sep 2014 | - | $19.28M(-10.4%) |
| Jun 2014 | - | $21.53M(-5.3%) |
| Mar 2014 | - | $22.74M(-2.4%) |
| Dec 2013 | $87.56M(+43.3%) | $23.30M(+7.6%) |
| Sep 2013 | - | $21.65M(-1.9%) |
| Jun 2013 | - | $22.06M(+9.5%) |
| Mar 2013 | - | $20.16M(+14.6%) |
| Dec 2012 | $61.09M(+15.2%) | $17.59M(+22.4%) |
| Sep 2012 | - | $14.37M(-0.5%) |
| Jun 2012 | - | $14.43M(-0.3%) |
| Mar 2012 | - | $14.48M(+476.5%) |
| Dec 2011 | $53.02M(+2.5%) | $2.51M(-9.7%) |
| Sep 2011 | - | $2.78M(+8.5%) |
| Jun 2011 | - | $2.56M(+14.7%) |
| Mar 2011 | - | $2.23M(-73.3%) |
| Dec 2010 | $51.70M(-18.8%) | $8.37M(-18.2%) |
| Sep 2010 | - | $10.23M(+13.1%) |
| Jun 2010 | - | $9.04M(-2.3%) |
| Mar 2010 | - | $9.26M(+32.6%) |
| Dec 2009 | $63.70M(-33.9%) | $6.98M(-105.9%) |
| Sep 2009 | - | -$118.17M(-1498.0%) |
| Jun 2009 | - | $8.45M(-59.7%) |
| Mar 2009 | - | $20.96M(-19.0%) |
| Dec 2008 | $96.32M(+43.9%) | $25.86M(-2.2%) |
| Sep 2008 | - | $26.45M(+15.3%) |
| Jun 2008 | - | $22.95M(+24.4%) |
| Mar 2008 | - | $18.45M(+12.9%) |
| Dec 2007 | $66.96M(+13.2%) | $16.34M(+12.2%) |
| Sep 2007 | - | $14.57M(-12.3%) |
| Jun 2007 | - | $16.62M(+2.5%) |
| Mar 2007 | - | $16.21M(+33.1%) |
| Dec 2006 | $59.15M(-16.9%) | $12.18M(-10.9%) |
| Sep 2006 | - | $13.67M(-2.2%) |
| Jun 2006 | - | $13.98M(-10.7%) |
| Mar 2006 | - | $15.66M(-15.3%) |
| Dec 2005 | $71.18M(+56.4%) | - |
| Mar 2005 | - | $18.50M(+228.9%) |
| Dec 2004 | $45.52M(+53.8%) | - |
| Mar 2004 | - | $5.63M |
| Dec 2003 | $29.60M(+305.9%) | - |
| Dec 2002 | $7.29M(+1718.5%) | - |
| Dec 2001 | $401.00K | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual operating expenses year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual total operating expenses?
The current annual operating expenses of MDGL is $671.77M
What is the all time high annual operating expenses for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual total operating expenses is $671.77M
What is Madrigal Pharmaceuticals, Inc. annual operating expenses year-on-year change?
Over the past year, MDGL annual total operating expenses has changed by +$291.28M (+76.55%)
What is Madrigal Pharmaceuticals, Inc. quarterly total operating expenses?
The current quarterly operating expenses of MDGL is $250.56M
What is the all time high quarterly operating expenses for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $250.56M
What is Madrigal Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
Over the past year, MDGL quarterly total operating expenses has changed by +$74.29M (+42.15%)